It has been discovered that GPIIb/IIIa promotes NEU1 surface translocation and platelet desialylation in GPIIb/IIIa-containing ITP patients relies on FcγRIIA signaling on the surface of splenic macrophages rather than the platelet activation pathway (7). This evidence concerns the gene ITGA2B and autoimmune thrombocytopenic purpura.